Skip to main content
. 2014 Dec 28;20(48):18458–18465. doi: 10.3748/wjg.v20.i48.18458

Table 6.

Biochemical indicators after 8-wk treatment (mean ± SD)

Group Time n PTA (%) n TBIL (µmol/L) n ALB (g/L) n ALT (IU/L)
MMC Before treatment 28 26.80 ± 10.91 30 326.29 ± 210.47 28 28.07 ± 4.56 30 202.00 ± 249.20
After treatment 18 43.14 ± 18.60 21 176.13 ± 185.70 21 28.57 ± 4.56 21 39.90 ± 30.19
“TQD” Before treatment 61 32.50 ± 12.15 65 314.04 ± 160.20 65 29.54 ± 4.75 65 254.80 ± 424.32
After treatment 55 43.59 ± 22.08 63 242.54 ± 229.05 63 31.30 ± 4.77c 63 78.70 ± 161.80
“TTK” Before treatment 36 28.63 ± 11.28 36 369.13 ± 198.06 36 27.82 ± 4.52 36 189.52 ± 241.97
After treatment 30 32.55 ± 15.58 33 339.40 ± 270.09a 33 30.72 ± 2.89e 33 70.12 ± 82.23

Normal range: PTA: 80%-120%; TBIL: 3.4-20.5 μmol/L; ALB: 35-55 g/L; ALT: 0-46 IU/L.

a

P < 0.05 vs MMC group;

c

P < 0.05 vs MMC group,

e

P < 0.05 vs MMC group.